François Montastruc, MD, PhD
François Montastruc, MD, PhD
Department of Clinical and Medical Pharmacology Toulouse, TMBI, Univ. Toulouse
No verified email
Cited by
Cited by
Pharmacovigilance, risks and adverse effects of self-medication
JL Montastruc, E Bondon-Guitton, D Abadie, I Lacroix, A Berreni, ...
Therapies 71 (2), 257-262, 2016
Trends in first gabapentin and pregabalin prescriptions in primary care in the United Kingdom, 1993-2017
F Montastruc, SY Loo, C Renoux
Jama 320 (20), 2149-2151, 2018
Potentially inappropriate medication use among patients with Alzheimer disease in the REAL. FR cohort: be aware of atropinic and benzodiazepine drugs!
F Montastruc, V Gardette, C Cantet, A Piau, M Lapeyre-Mestre, B Vellas, ...
European journal of clinical pharmacology 69, 1589-1597, 2013
Serious bradycardia and remdesivir for coronavirus 2019 (COVID-19): a new safety concerns
A Touafchia, H Bagheri, D Carrié, G Durrieu, A Sommet, L Chouchana, ...
Clinical Microbiology and Infection 27 (5), 791. e5-791. e8, 2021
Cancer risk of anti-TNF-α at recommended doses in adult rheumatoid arthritis: a meta-analysis with intention to treat and per protocol analyses
G Moulis, A Sommet, J Bene, F Montastruc, L Sailler, JL Montastruc, ...
PLoS One 7 (11), e48991, 2012
Serotonin syndrome: analysis of cases registered in the French pharmacovigilance database
D Abadie, V Rousseau, S Logerot, J Cottin, JL Montastruc, F Montastruc
Journal of clinical psychopharmacology 35 (4), 382-388, 2015
What is pharmacoepidemiology? Definition, methods, interest and clinical applications
JL Montastruc, J Benevent, F Montastruc, H Bagheri, F Despas, ...
Therapies 74 (2), 169-174, 2019
Hepatic disorders with the use of remdesivir for coronavirus 2019
F Montastruc, S Thuriot, G Durrieu
Clinical Gastroenterology and Hepatology 18 (12), 2835-2836, 2020
Risk of thrombosis in patients with primary immune thrombocytopenia and antiphospholipid antibodies: A systematic review and meta-analysis
G Moulis, A Audemard-Verger, L Arnaud, C Luxembourger, F Montastruc, ...
Autoimmunity reviews 15 (3), 203-209, 2016
Role of serotonin 5-HT2C and histamine H1 receptors in antipsychotic-induced diabetes: a pharmacoepidemiological-pharmacodynamic study in VigiBase
F Montastruc, A Palmaro, H Bagheri, L Schmitt, JL Montastruc, ...
European Neuropsychopharmacology 25 (10), 1556-1565, 2015
Exposure to atropinic drugs and frailty status
F Moulis, G Moulis, L Balardy, S Gérard, F Montastruc, S Sourdet, ...
Journal of the American Medical Directors Association 16 (3), 253-257, 2015
The importance of drug–drug interactions as a cause of adverse drug reactions: a pharmacovigilance study of serotoninergic reuptake inhibitors in France
F Montastruc, A Sommet, E Bondon-Guitton, G Durrieu, E Bui, H Bagheri, ...
European journal of clinical pharmacology 68, 767-775, 2012
Antidepressants and movement disorders: a postmarketing study in the world pharmacovigilance database
A Revet, F Montastruc, A Roussin, JP Raynaud, M Lapeyre-Mestre, ...
BMC psychiatry 20 (1), 1-13, 2020
Adverse drug reactions to self‐medication: a study in a pharmacovigilance database
A Berreni, F Montastruc, E Bondon‐Guitton, V Rousseau, D Abadie, ...
Fundamental & clinical pharmacology 29 (5), 517-520, 2015
A comparative study of QT prolongation with serotonin reuptake inhibitors
A Ojero-Senard, J Benevent, E Bondon-Guitton, G Durrieu, L Chebane, ...
Psychopharmacology 234, 3075-3081, 2017
Abatacept in rheumatoid arthritis and the risk of cancer: a world observational post-marketing study
S de Germay, H Bagheri, F Despas, V Rousseau, F Montastruc
Rheumatology 59 (9), 2360-2367, 2020
Psychiatric disorders and hydroxychloroquine for coronavirus disease 2019 (COVID-19): a VigiBase study
P Garcia, A Revet, A Yrondi, V Rousseau, Y Degboe, F Montastruc
Drug Safety 43, 1315-1322, 2020
Serious central nervous system side effects of cephalosporins: a national analysis of serious reports registered in the French Pharmacovigilance Database
C Lacroix, F Kheloufi, F Montastruc, Y Bennis, V Pizzoglio, J Micallef
Journal of the neurological sciences 398, 196-201, 2019
Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study
D Abrahami, A Douros, H Yin, HY Oriana, JL Faillie, F Montastruc, ...
bmj 363, 2018
Analysis of patients' narratives posted on social media websites on benfluorex's (Mediator®) withdrawal in France
M Abou Taam, C Rossard, L Cantaloube, N Bouscaren, G Roche, ...
Journal of clinical pharmacy and therapeutics 39 (1), 53-55, 2014
The system can't perform the operation now. Try again later.
Articles 1–20